Industry NewsAlmac Supports Clients in Response to New, Stringent, FDA Heavy Metal Mandates by Investing in ICP-MS Equipment
Product NewsGenomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
Product NewsAlmac Launches SupplyTraQ™ Technology Solution to Streamline Clinical Trial Supply Administration
Product NewsAlmac Discovery Announces Licensing of ALM201 to Shin Poong for Development and Marketing in South Korea
Product NewsAlmac Successfully Completes Knowledge Transfer Partnership with Queens University with Highest Accolade
